$KRTL Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.